NASDAQ$CSTL
Castle Biosciences Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Castle Biosciences Inc Q1 fiscal 2026: $83.68B revenue, $14.5M net loss
for the year ended December 31, 2025 filed with the Securities and Exchange Commission on February 26, 2026. (SEC accession 0001628280-26-031263)
- Revenue: $83.68B
- Net loss: $14.5M
- Diluted EPS: $-0.49
- Operating income: $-18.4M
Headline financials
Revenue & EPS history
Castle Biosciences · Revenue · Quarterly
$83.7M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2026
+0.1%
Avg return
Earnings day
-2.1%
Avg return
5 days after
+1.2%
Avg return
30 days after
41%
13 / 32 earnings
Positive
+21.8%
Q3 2025
Best reaction
-28.0%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.6% | -22.6% | — | |
| Q4 2025 | -7.3% | -11.6% | -26.2% | |
| Q3 2025 | +21.8% | +27.1% | +52.4% | |
| Q1 2025 | -11.7% | -10.5% | -9.2% | |
| Q4 2024 | -14.2% | -15.7% | -21.1% | |
| Q3 2024 | -6.0% | +0.4% | -3.8% | |
| Q2 2024 | +11.8% | +20.4% | +29.8% | |
| Q1 2024 | +10.5% | +8.1% | +5.6% | |
| Q4 2023 | -28.0% | -15.4% | -11.7% | |
| Q3 2023 | +14.5% | +14.6% | +27.2% | |
| Q2 2023 | +12.3% | +7.0% | +17.6% | |
| Q1 2023 | -0.2% | +2.6% | +3.0% | |
| Q4 2022 | -7.7% | -0.3% | -10.2% | |
| Q3 2022 | -6.0% | -23.7% | -0.4% | |
| Q2 2022 | +0.3% | +11.1% | -12.6% | |
| Q1 2022 | -4.1% | -6.8% | +3.1% | |
| Q4 2021 | +4.5% | -5.4% | -1.5% | |
| Q3 2021 | -7.2% | -13.2% | -23.2% | |
| Q2 2021 | -4.9% | -10.3% | +6.5% | |
| Q1 2021 | -9.5% | -8.5% | +17.5% | |
| Q4 2020 | -9.9% | -6.9% | +2.3% | |
| Q3 2020 | -3.3% | -2.6% | +12.3% | |
| Q2 2020 | +0.1% | -1.1% | +19.8% | |
| Q1 2020 | +17.1% | +18.9% | +22.4% | |
| Q1 2019 | +17.1% | +18.9% | +22.4% | |
| Q1 2018 | -1.5% | -18.2% | -4.7% | |
| Q4 2019 | -1.5% | -18.2% | -4.7% | |
| Q3 2018 | +20.0% | -7.0% | -6.1% | |
| Q3 2019 | +18.2% | +30.3% | +32.9% | |
| Q4 2018 | -6.9% | -9.0% | -33.8% | |
| Q2 2019 | -6.9% | -9.0% | -33.8% | |
| Q2 2018 | -6.9% | -9.0% | -33.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro